3: Abstract 1: Improvement of experimental mouse models in Inflammatory Bowel Diseases using flexible video endoscopic colon evaluation2nd Y-ECCO Basic Science Workshop
2016
1
3: Personalising Paediatric IBD: Identification of high and low risk patients at diagnosis3rd P-ECCO Educational Course
2016
1
3: Session 2: Patient reported outcomes measures. New data2nd Advanced ECCO: EduCational COurse for Industry
2016
1
40: Best abstract: Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate to severe Ulcerative Colitis: Results from two phase 3 randomised controlled trialsECCO'16 Amsterdam
2016
1
41: Best abstract: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s Disease: Interim analysis from the phase 2 FITZROY studyECCO'16 Amsterdam
2016
1
46: Best abstract: Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate to severe Crohn’s Disease: Results of a Phase 2b randomised placebo-controlled trialECCO'16 Amsterdam
2016
1